Thryve Peptides
GLP-3R (10mg) 10 pack
GLP-3R (10mg) 10 pack
Couldn't load pickup availability
GLP-3R 10MG
Tri-agonist innovation — engineered for next-generation peptide research.
- GLP-3R is a synthetic peptide analog designed as a triple receptor agonist acting on GLP-1, GIP, and glucagon receptors.
- Studied in controlled laboratory research for its potential influence on energy expenditure, glucose regulation, and metabolic pathways.
- Each batch independently verified by Vanguard Laboratory for purity and composition.
For laboratory research use only. Not for human consumption.
Scientific Evidence
Retatrutide (LY3437943) is a long-acting peptide analog that functions as a triple receptor agonist on GLP-1, GIP, and glucagon receptors.
Preclinical studies demonstrate its ability to promote glucose-dependent insulin secretion, increase energy expenditure, and reduce adiposity in animal models (PubMed 37466719).
Phase 2 clinical research has further characterized its pharmacodynamic effects on multi-receptor signaling and metabolic outcomes (PubMed 37466722).
Regulatory Status: Retatrutide is not FDA-approved for human or veterinary use. It is supplied exclusively for laboratory research applications.
